Highlights and Quick Summary
- SG&A Expenses for the quarter ending March 31, 2023 was $2.34 Million (a -10.25% decrease compared to previous quarter)
- Year-over-year quarterly SG&A Expenses decreased by -8.81%
- Annual SG&A Expenses for 2022 was $11.2 Million (a 9.54% increase from previous year)
- Annual SG&A Expenses for 2022 was $10.3 Million (a 338.2% increase from previous year)
- Annual SG&A Expenses for 2021 was $2.34 Million (a 0.0% decrease from previous year)
- Twelve month SG&A Expenses ending March 31, 2023 was $10 Million (a -10.74% decrease compared to previous quarter)
- Twelve month trailing SG&A Expenses increased by 35.17% year-over-year
Trailing SG&A Expenses for the last four month:
31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
---|---|---|---|
$10 Million | $11.2 Million | $9.36 Million | $7.43 Million |
Visit stockrow.com/DRTS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical SG&A Expenses of Alpha Tau Medical Ltd.
Most recent SG&A Expensesof DRTS including historical data for past 10 years.Interactive Chart of SG&A Expenses of Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. SG&A Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | $2.34 | – | – | – | – |
2022 | $2.61 | $2.53 | $2.56 | $3.55 | $11.25 |
2021 | $0.71 | $0.6 | $0.48 | $0.55 | $2.34 |
2020 | – | – | – | $0.0 | $1.7 |
2019 | – | – | – | – | $1.37 |
Business Profile of Alpha Tau Medical Ltd.
Sector: Healthcare
Industry: Biotechnology